logo







Home>Companies>Abcellera-nas-abcl


Abcellera (nas: abcl)

Abcellera (nas: abcl)



AbCellera (NAS: ABCL) is a biotechnology company specializing in antibody discovery and development, utilizing advanced technology to identify optimal clinical candidates with enhanced precision and speed.
Sign up today to get real-time market insights on Abcellera (nas: abcl) and hundreds of other pre-IPO companies



Abcellera (nas: abcl) Overview

2012
Biotech
https://www.abcellera.com



Abcellera (nas: abcl) Live Market Data

$00000000
$00000000




Abcellera (nas: abcl) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO12/11/2020
Series B5/27/2020
Secondary Transaction - Open Market1/1/2020
Series A9/27/2018
Seed Round8/9/2014




Abcellera (nas: abcl) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
DCVCSeed RoundSeed Round (2014-08-09)
Alpha Wave GlobalSeries BSeries B (2020-05-27)
Founders FundSeries BSeries B (2020-05-27)
Sherpalo VenturesSeries BSeries B (2020-05-27)
Viking Global InvestorsSeries BSeries B (2020-05-27)




Abcellera (nas: abcl) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Abcellera (nas: abcl) data




Abcellera (nas: abcl) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Abcellera (nas: abcl) data




Latest Abcellera (nas: abcl) News







Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.